thought call
portfolio look pois deliv flat growth view
like keep share hold pattern near term remain encourag
launch new product like prolia aimovig amjevita hesit presum
enough off-set market matur competit pressur face
enbrel forecast neulasta/neupogen
continu linchpin hesit stock short-term despit
compani sizeabl cash gener year forecast top-lin declin
peer make moment share upsid difficult
view bottom line continu expect acceler growth
low tax rate addit share repurchas program expect
view access global cash quit attract remain
seen execut strategi bd would urg manag
priorit potenti accret pipelin asset deal could ultim augment
current revenu trend overal pipelin valu encourag tonight
announc manag chang murdo gordon join david rees
succeed sean harper believ underscor commit
pipelin without transform deal horizon difficulti see much
upsid share thu reiter equal weight rate pt
aimovig set stage migrain market concern linger overal growth
profil base busi encourag aimovig posit first-to-
market allow partner novarti set commerci stage price
contract earli exposur migrain specialist caution howev
strong launch may suffici counteract neg headwind face
pt increas model updat due recent strong perform biotech peer
believ trade ep vs prior yield
pt forecast ep ep
revenu estim come
quarterli annual ep usd
consensu number thomson reuter receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
rais usd
return equiti ttm
link barclay live interact chart
equal weight despit improv pipelin
committ y/i dividend increas
improv margin compani revenu growth
outlook remain modest contribut
evolocumab kyproli alreadi reflect
estim view risk/reward profil
balanc expect market look greater
revenu accler cost save
pipelin adopt faster
anticip increas visibl biosimilar
threat neulasta/enbrel unlik materi
near-to-short term
launch slower expect
increas certainti time
biosimilar enbrel neulasta launch like
come signific price discount brand
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
geoff meacham ph herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli
relat specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
author contribut research report research analyst unless otherwis indic
public date top report reflect local time report produc may differ releas date provid
gmt
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
procedur pleas
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis barclay research depart
oper independ absa research depart absa research produc absa bank limit act corpor
invest bank divis part barclay africa group limit affili invest bank barclay bank plc elig
client may receiv research report research depart may reach differ conclus may contain differ
conflict forecast recommend trade idea
price sourc thomson reuter last avail close price relev trade market unless anoth time sourc
